Cathepsin X (314-325)

Cathepsin X (314-325) is a synthetic peptide fragment corresponding to amino acid residues 314 through 325 of the human Cathepsin X protein, a lysosomal cysteine protease involved in diverse physiological and pathological processes. As a peptide compound, it represents a functionally significant region of Cathepsin X, enabling researchers to dissect structural motifs, substrate interactions, and regulatory mechanisms specific to this protease. Its sequence offers a valuable tool for elucidating the molecular underpinnings of Cathepsin X activity, substrate specificity, and its broader roles in proteolytic pathways, cell signaling, and protein turnover.

Enzyme substrate profiling: The Cathepsin X (314-325) peptide serves as a defined substrate or substrate mimic for in vitro enzymatic assays aimed at characterizing the catalytic properties of Cathepsin X and related cysteine proteases. By providing a precise sequence derived from the native protein, it enables detailed kinetic analyses, cleavage site mapping, and comparative studies of protease-substrate recognition. This application supports the development of selective inhibitors and the exploration of enzyme specificity, which is crucial for understanding proteolytic regulation in cellular contexts.

Antibody generation and epitope mapping: Researchers utilize this peptide fragment as an immunogen or as a target for affinity purification in the production of sequence-specific antibodies against Cathepsin X. Its defined epitope allows for the generation of monoclonal or polyclonal antibodies with high specificity, facilitating downstream applications such as immunoblotting, immunoprecipitation, and immunohistochemistry. These antibodies are instrumental in detecting Cathepsin X expression, localization, and post-translational modifications in various biological samples.

Protein-protein interaction studies: The Cathepsin X (314-325) peptide can be employed in binding assays to probe interactions with endogenous inhibitors, cofactors, or regulatory proteins. By mimicking a segment of the full-length enzyme, it provides a platform for mapping binding sites and elucidating molecular determinants of protein-protein association. Such studies contribute to a deeper understanding of the regulatory networks governing protease function and may inform the design of targeted modulators.

Peptide-based inhibitor screening: In drug discovery and biochemical research, this peptide is valuable for high-throughput screening of small molecule or peptide-based inhibitors targeting Cathepsin X activity. By serving as a representative substrate or competitive ligand, it enables the identification and characterization of compounds that modulate protease function. This approach is particularly relevant for efforts aimed at developing research tools or chemical probes to dissect Cathepsin X-mediated pathways.

Structural and conformational analyses: The defined sequence of Cathepsin X (314-325) supports studies investigating peptide secondary structure, stability, and conformational dynamics using techniques such as circular dichroism spectroscopy, NMR, or molecular modeling. Insights gained from these analyses inform the understanding of substrate recognition motifs, folding behavior, and the influence of post-translational modifications or sequence variations. Such structural information is essential for rational design of peptide analogs and for elucidating the molecular basis of Cathepsin X function in health and disease.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling